Faculty of Pharmacy, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
Drug Metab Pharmacokinet. 2012;27(3):360-4. doi: 10.2133/dmpk.dmpk-11-sh-080. Epub 2011 Dec 27.
The purpose of this study was to examine whether the presence of multiple binding sites can explain the pleiotropy of substrate recognition by OATP2B1, using Xenopus oocytes expressing OATP2B1. OATP2B1-mediated uptake of estrone-3-sulfate apparently exhibited biphasic saturation kinetics, with Km values of 0.10 ± 0.05 and 29.9 ± 12.1 µM and Vmax values of 14.1 ± 6.4 and 995 ± 273 fmol/min/oocyte for high- and low-affinity sites, respectively. Contribution analysis revealed that transport of estrone-3-sulfate mediated by high- and low-affinity sites on OATP2B1 could be evaluated at the concentrations of 0.005 and 50 µM, respectively. pH-dependence study of OATP2B1-mediated estrone-3-sulfate uptake suggested that high- and low-affinity sites show different pH sensitivity. When the inhibitory effect of 12 compounds on estrone-3-sulfate uptake by high- and low-affinity sites on OATP2B1 was examined, 4 compounds appeared to be inhibitors of the high-affinity site on OATP2B1. Two other compounds appeared to be inhibitors for the low-affinity site and four others were inhibitory at both sites. These results indicated the presence of multiple binding sites on OATP2B1 with different affinity for drugs. Accordingly, it is likely that drug-drug and drug-beverage interactions occur only when two drugs share the same binding site on OATP2B1.
本研究旨在利用表达 OATP2B1 的非洲爪蟾卵母细胞,探讨是否存在多个结合位点可以解释 OATP2B1 对底物识别的多效性。OATP2B1 介导的雌酮-3-硫酸盐摄取显然表现出双相饱和动力学,高亲和力和低亲和力位点的 Km 值分别为 0.10 ± 0.05 和 29.9 ± 12.1 µM,Vmax 值分别为 14.1 ± 6.4 和 995 ± 273 fmol/min/oocyte。贡献分析表明,OATP2B1 上高亲和力和低亲和力位点介导的雌酮-3-硫酸盐转运可以在 0.005 和 50 µM 的浓度下进行评估。OATP2B1 介导的雌酮-3-硫酸盐摄取的 pH 依赖性研究表明,高亲和力和低亲和力位点显示出不同的 pH 敏感性。当考察 12 种化合物对 OATP2B1 上高亲和力和低亲和力位点介导的雌酮-3-硫酸盐摄取的抑制作用时,4 种化合物似乎是 OATP2B1 上高亲和力位点的抑制剂。另外两种化合物似乎是低亲和力位点的抑制剂,还有四种化合物在两个位点都具有抑制作用。这些结果表明 OATP2B1 上存在多个具有不同药物亲和力的结合位点。因此,只有当两种药物在 OATP2B1 上具有相同的结合位点时,才可能发生药物-药物和药物-饮料相互作用。